BBA

Baker Bros. Advisors Portfolio holdings

AUM $17.4B
1-Year Est. Return 131.5%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+131.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.4B
AUM Growth
+$337M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
93
New
Increased
Reduced
Closed

Top Buys

1
+$194M
2
+$151M
3
+$127M
4
MIRM icon
Mirum Pharmaceuticals
MIRM
+$42M
5
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$31.4M

Top Sells

1
+$63.8M
2
+$51.4M
3
+$38.4M
4
BNTX icon
BioNTech
BNTX
+$25.6M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$22M

Sector Composition

1 Healthcare 99.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INCY icon
1
Incyte
INCY
$19.3B
$2.89B 16.62%
30,744,412
+421
ONC
2
BeOne Medicines Ltd
ONC
$29.9B
$2.61B 15%
8,799,053
INSM icon
3
Insmed
INSM
$23.2B
$1.21B 6.97%
7,421,111
+828,365
MDGL icon
4
Madrigal Pharmaceuticals
MDGL
$11.5B
$1.12B 6.44%
2,141,701
ACAD icon
5
Acadia Pharmaceuticals
ACAD
$3.71B
$955M 5.48%
42,896,690
RVMD icon
6
Revolution Medicines
RVMD
$33.5B
$929M 5.34%
9,555,357
+100,000
CELC icon
7
Celcuity
CELC
$6.48B
$904M 5.19%
7,915,792
KOD icon
8
Kodiak Sciences
KOD
$2.3B
$759M 4.36%
19,919,186
KYMR icon
9
Kymera Therapeutics
KYMR
$6.7B
$721M 4.14%
8,657,242
SMMT icon
10
Summit Therapeutics
SMMT
$13.6B
$690M 3.96%
36,391,063
PRAX icon
11
Praxis Precision Medicines
PRAX
$9.76B
$565M 3.24%
1,753,198
+626,710
RYTM icon
12
Rhythm Pharmaceuticals
RYTM
$6.05B
$487M 2.8%
5,604,483
ALKS icon
13
Alkermes
ALKS
$7.03B
$354M 2.03%
10,012,267
GRAL
14
GRAIL Inc
GRAL
$3.08B
$208M 1.2%
4,028,614
+1,943,281
EWTX icon
15
Edgewise Therapeutics
EWTX
$3.68B
$207M 1.19%
6,575,940
IONS icon
16
Ionis Pharmaceuticals
IONS
$12.6B
$154M 0.88%
2,047,727
+255,886
KNSA icon
17
Kiniksa Pharmaceuticals
KNSA
$3.72B
$136M 0.78%
2,826,246
IMVT icon
18
Immunovant
IMVT
$6.84B
$136M 0.78%
5,457,881
ROIV icon
19
Roivant Sciences
ROIV
$21.6B
$135M 0.77%
4,867,723
-687,294
IDYA icon
20
IDEAYA Biosciences
IDYA
$2.59B
$131M 0.76%
3,946,515
+327,689
ARWR icon
21
Arrowhead Research
ARWR
$11B
$125M 0.72%
1,992,783
-182,862
STOK icon
22
Stoke Therapeutics
STOK
$1.93B
$109M 0.62%
3,336,697
IMTX icon
23
Immatics
IMTX
$1.57B
$107M 0.62%
10,916,693
-1,177,401
ABCL icon
24
AbCellera Biologics
ABCL
$1.88B
$106M 0.61%
30,275,938
+2,750,298
ABVX
25
Abivax
ABVX
$10.6B
$97.5M 0.56%
875,796
1
2 3 4